Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.5.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CR.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BT.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.129 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used